Women With a Partial Mole During Their First Pregnancy and Diagnosed Earlier in Gestation Are at Increased Risk of Developing Gestational Trophoblastic Neoplasia
暂无分享,去创建一个
[1] P. S. Lim,et al. Outcome of molar pregnancies in Malaysia: A tertiary centre experience , 2013, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[2] J. Lurain. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. , 2010, American journal of obstetrics and gynecology.
[3] R. Berkowitz,et al. Molar pregnancy: pathology and management , 2008 .
[4] R. Berkowitz,et al. Current management of gestational trophoblastic diseases. , 2009, Gynecologic oncology.
[5] Y. Xiang,et al. Changes of clinical features in hydatidiform mole: analysis of 113 cases. , 2008, The Journal of reproductive medicine.
[6] H. Boussen,et al. Gestational trophoblastic disease in Tunisia. , 2008, La Tunisie medicale.
[7] R. Berkowitz,et al. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. , 2006, The Journal of reproductive medicine.
[8] R. Berkowitz,et al. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies. , 2006, The Journal of reproductive medicine.
[9] B. Hancock,et al. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. , 2006, The Journal of reproductive medicine.
[10] L. Sunde,et al. Predictors of Low Risk of Persistent Trophoblastic Disease in Molar Pregnancies , 2006, Obstetrics and gynecology.
[11] M. Quinn,et al. Persistent trophoblast disease following partial molar pregnancy , 2006, The Australian & New Zealand journal of obstetrics & gynaecology.
[12] E. Kohorn. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. , 2002, The Journal of reproductive medicine.
[13] R. Berkowitz,et al. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. , 2002, The Journal of reproductive medicine.
[14] J. Tidy,et al. Current management of molar pregnancy. , 2002, The Journal of reproductive medicine.
[15] FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee. , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[16] R. Mclellan,et al. Gestational trophoblastic disease. , 2001, Obstetrics and gynecology clinics of North America.
[17] R. Berkowitz,et al. Gestational Trophoblastic Disease , 2007, Current treatment options in oncology.
[18] M. Seckl,et al. Choriocarcinoma and partial hydatidiform moles , 2000, The Lancet.
[19] A. Ayhan,et al. Predictors of persistent disease in women with complete hydatidiform mole. , 1996, The Journal of reproductive medicine.
[20] S. Lawler,et al. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole , 1990, The Lancet.
[21] R. Berkowitz,et al. Persistent gestational trophoblastic tumor after partial hydatidiform mole. , 1990, Gynecologic oncology.
[22] R. Berkowitz,et al. Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease , 1986 .
[23] R. Berkowitz,et al. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. , 1986, Gynecologic oncology.